 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 05/05/2025 |
$19.86 |
$20.05 |
$19.30 |
$19.82 |
1.96M | | 05/06/2025 |
$19.30 |
$19.34 |
$15.65 |
$15.99 |
5.16M | | 05/07/2025 |
$16.20 |
$16.24 |
$15.51 |
$16.23 |
2.64M | | 05/08/2025 |
$16.26 |
$17.75 |
$15.64 |
$17.25 |
3.15M | | 05/09/2025 |
$17.40 |
$18.75 |
$17.37 |
$17.41 |
2.38M |
|
|
| Beam Therapeutics Inc. is a biotechnology company developing precision genetic medicines through base editing. Co.'s suite of gene editing technologies is anchored by base editing, a technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the deoxyribonucleic acid. Its lead programs are focused on sickle cell disease and alpha-1 antitrypsin deficiency, and it is also advancing programs in other genetic diseases, as well as immunology/oncology. Its primary programs include BEAM-101, Engineered Stem Cell Antibody Paired Evasion (ESCAPE), BEAM-302, BEAM-301 and BEAM-201. | |
|
Beam Therapeutics (BEAM) has the following price history information. Looking back at BEAM historical stock prices for the last five trading days, on May 05, 2025, BEAM opened at $19.86, traded as high as $20.05 and as low as $19.30, and closed at $19.82. Trading volume was a total of 1.96M shares. On May 06, 2025, BEAM opened at $19.30, traded as high as $19.34 and as low as $15.65, and closed at $15.99. Trading volume was a total of 5.16M shares. On May 07, 2025, BEAM opened at $16.20, traded as high as $16.24 and as low as $15.51, and closed at $16.23. Trading volume was a total of 2.64M shares. On May 08, 2025, BEAM opened at $16.26, traded as high as $17.75 and as low as $15.64, and closed at $17.25. Trading volume was a total of 3.15M shares. On May 09, 2025, BEAM opened at $17.40, traded as high as $18.75 and as low as $17.37, and closed at $17.41. Trading volume was a total of 2.38M shares.
BEAM Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Beam Therapeutics shares, starting with a $10,000 purchase of BEAM, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
02/07/2020 |
|
| End date: |
05/09/2025 |
|
| Start price/share: |
$20.62 |
|
| End price/share: |
$17.41 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-15.57% |
|
| Average Annual Total Return: |
-3.17% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$8,443.52 |
|
| Years: |
5.25 |
|
|
|
| Date |
Close |
| 05/05/2025 | $19.82 | | 05/06/2025 | $15.99 | | 05/07/2025 | $16.23 | | 05/08/2025 | $17.25 | | 05/09/2025 | $17.41 |
|
|
Free BEAM Email Alerts:
